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Abstract
Background: One of the well-defined and characterized protein modifications usually produced by oxidation is
carbonylation, an irreversible non-enzymatic modification of proteins. However, carbonyl groups can be introduced
into proteins by non-oxidative mechanisms. Reactive carbonyl compounds have been observed to have increased
in patients with renal failure. In the present work we have described a procedure designed as aldehyde capture to
calculate the protein carbonyl stress derived solely from lipid peroxidation.
Methods: Acrolein-albumin adduct was prepared as standard at alkaline pH. Rat liver microsomal membranes and
serum samples from patients with diabetic nephropathy were subjected to the aldehyde capture procedure and
aldol-protein formation. Before alkalinization and incubation, samples were precipitated and redisolved in 6M
guanidine. The absorbances of the samples were read with a spectrophotometer at 266 nm against a blank of
guanidine.
Results: Evidence showed abundance of unsaturated aldehydes derived from lipid peroxidation in rat liver
microsomal membranes and in the serum of diabetic patients with advanced chronic kidney disease. Carbonyl
protein and aldol-proteins resulted higher in the diabetic nephropathy patients (p < 0.004 and p < 0.0001
respectively).
Conclusion: The aldehyde-protein adduct represents a non oxidative component of carbonyl stress, independent
of the direct amino acid oxidation and could constitute a practical and novelty strategy to measure the carbonyl
stress derived solely from lipid peroxidation and particularly in diabetic nephropathy patients. In addition, we are in
a position to propose an alternative explanation of why alkalinization of urine attenuates rhabdomyolysis-induced
renal dysfunction.
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Background
Oxidation can cause proteins to suffer loss of catalytic
function, degradation, proteolysis and several degrees of
denaturation [1,2]. Protein oxidation increases during
aging and has been consistently associated with many
pathologies such as diabetes, atherosclerosis, cataracts,
renal damage, and more [3,4]. One of the well-defined
and characterized protein modifications usually pro-
duced by oxidation is carbonylation, an irreversible non-
enzymatic modification of proteins [5]. Therefore, oxida-
tion of protein can be measured by the addition of car-
bonyl groups. The spectrophotometric assay using 2, 4-
dinitrophenylhydrazine (DNPH) constitutes one of the
primary ways of detecting carbonyls, since it is relatively
easy, fast and inexpensive [6,7]. Carbonyl groups are
introduced into proteins by metal-catalyzed oxidation
and a variety of reactive nitrogen species (nitric oxide,
peroxinitrite), reactive chlorine species (hypochlorous
acid, nitryl chloride) and reactive oxygen species (hydro-
gen peroxide, hydroxyl radical, peroxiradicals, ozone,
etc.)[8-10].
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teins by non-oxidative mechanisms, and this can
increase carbonyl levels in proteins in an extensive man-
ner. Carbonyl groups can be introduced into proteins by
reaction with molecules such as acrolein, 4-hydroxy-2-
nonenal (HNE) and other alpha-beta unsaturated alde-
hydes derived from lipid peroxidation that react with
protein residues via several kinds of reactions, included
Schiff base formation and Michael addition reactions
[11]. Hence, the presence of carbonyl is not necessarily
indicative of direct oxidation of amino acid residues in
proteins, and the importance of lipid peroxidation and
the participation of reactive low molecular weight alde-
hydes on protein carbonylation have been demonstrated
[12-14].
Reactive carbonyl compounds derived from lipids and
carbohydrates by both oxidative and non-oxidative
routes have been observed to have increased in patients
with renal damage. These compounds react with pro-
teins, resulting in the condition described as “carbonyl
stress”, which underlies the development of uremic
complications [15]. Uremic plasma contains elevated
levels of low weight molecular carbonyl compounds
[16]. These do not seem to be secondary products of
protein glycation nor do they depend on glucose plasma
concentration, but more probably are reactive carbonyl
compounds derived from carbohydrates, lipids and
amino acids [16,17]. Rhabdomyolisis with extensive
muscle release of myoglobyn (Mb) generates kidney
damage caused by redox cycling of the heme radicals
[18]. Lipid peroxidation catalyzed by the hemoprotein’s
radicals is probably the more documented explanation
for the oxidative damage associated with rhabdomyolysis
[19], and this condition constitutes another potential
source of the alpha beta unsaturated aldehydes and car-
bonyl stress in the kidney.
Proteins have an enormous capability to conjugate
with alpha-betha unsaturated aldehydes. At alkaline pH
albumin isomerizes and exposes cysteine thiolate anions.
Previous research indicates that the highly nucleophilic
thiolate state is the adduct target for the alfa, beta-unsa-
turated carbonyl compounds [20-22]. We found that, in
addition to the described reactions, unsaturated alde-
hydes at alkaline pH can undergo aldolic condensation
linked to the proteins and form stable adducts with cor-
responding increases in absorbance at 266 nm. Taking
advantage of properties mentioned we implement a sim-
ple procedure to calculate the abundance of these com-
pounds from a sample containing proteins such as
serum or plasma (aldehyde capture).
We observed an intense aldehyde capture during the
rat liver microsomal peroxidation catalyzed by NADPH,
demonstrating the participation of membranes fatty
acids phospholipids as the source of alpha beta
unsaturated aldehydes. Then, serum samples were sub-
jected to the aldehyde capture and the results permitted
us to corroborate the alpha-beta unsaturated aldehyde-
dependent carbonyl stress derived from lipid peroxida-
tion in the serum of diabetic patients with advanced
chronic kidney disease.
Results
Acrolein condensation proceeds even with protein linked
(aldehyde capture)
The kinetic of the aldehyde condensation in an alkali-
catalyzed aldol reaction can be observed in Figure 1
(scan and bars 0 to 5). Acrolein in the presence of albu-
min polymerized (266 nm) in their bulk solution in a
time dependent manner (0-50 minutes). A second inde-
pendent peak can be observed at 280 nm (Figure 1 scan,
line 1) and corresponds to the intrinsic absorbance of
the albumin, which does not change with respect to
time. The same strong absorbance of aldehyde at 266
nm in fatty acids protein-free solutions can be presented
(Additional File 1) and follows a similar reaction kinetic,
as been observed elsewhere [23,24]. Increasing amounts
of acrolein-albumin adduct (aldol-proteins) were used to
perform standard curves, one of which is presented in
Figure 2. The slopes of each curve are determined by
differences in absorbance at 266 nm in relation with
adduct concentration. This way the average slope values
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Figure 1 Spectral scans and the kinetic of aldol-protein
formation with respect to the time. At the internal graph,
aldehyde condensation of acrolein in the presence of albumin at
alkaline pH proceeds from 0 to 50 minutes (number 0-5 on the
line), making grow the absorbance denoted by ascending peaks at
266 nm. One more peak, corresponding to protein absorbance is
showing around 280 nm but this time without apparent time
dependent changes. At right side the bars denoting the exponential
behave corresponding to the protein-aldehyde condensation
kinetic. The data depicted correspond to one of the curves
obtained using the described experimental conditions such as was
explained in material and method section.
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Albumin-acrolein no aldol and the aldol-protein respec-
tively. Some no catalyzed aldehyde captures and then
spontaneous aldol-protein formation can be observed
(Albumin-acrolein (no aldol) cuerve).
Aldol-protein formation in the catalyzed microsomal
peroxidation and its inhibition with bisulfite
The products of catalyzed microsomal peroxidation
increase the absorbance of the control sample at 266 nm
by a factor of more than 14 (Figure 3, #1 vs. #3). Protein
presented in the reaction mixture corresponds exclusively
to the membrane proteins, and then the product obtained
after sample precipitation corresponds to the aldol-pro-
teins. When sodium bisulfite was added at the end of the
incubation period of peroxidation, the absorbance fell (Fig-
ure 3, #4), (p < 0.0001) and reached values close to its con-
trol. Even in the control case (MICROSOMES NO
PEROXIDATION), a fall of the initial amount could be
observed (Figure 3 #2; p < 0.01) with the addition of bisul-
fite. Bisulfite interferes directly with carbonyl groups
derived from aldehydes in the aldolic condensation.
Protein carbonyl and Aldol-proteins in serum samples
from patients with diabetic nephropathy
Table 1 summarizes the aldol-protein and protein car-
bonyl content of serum samples of 21 healthy subjects
and 18 patients with diabetic nephropathy. All the
patients have a GFR in the range 16-45 ml/min/1.73 m
3
and chronic stage 3-4 kidney disease (moderate to
severe GFR reduction); meanwhile the healthy volun-
teers presented a GFR > 90 ml/min/1.73 m
3, calculated
from creatinine concentration and the Cockroft-Gault
formula [25]. Carbonyl protein and aldol-proteins
resulted higher in the diabetic nephropathy patients (p <
0.004 and p < 0.0001 respectively). Introduction of car-
bonyl groups to the serum sample proteins after alde-
hyde capture corroborated the aldehyde incorporation
(p < 0.002) (A comparative graph is presented in Addi-
tional file 2).
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Figure 2 Standard curve representing the linear relationship
between the protein-acrolein adduct concentration and the
absorbance at 266 nm (Aldol-Proteins). Parallel standard curves
were made with only albumin and albumin plus acrolein without
the addition of sodium hydroxide (Albumin and Albumin-acrolein
no aldol). The standard curves performed in this way correspond to
the values of the intrinsic absorbance of albumin (and albumin-
acrolein no aldol) around the 280 nm. Samples for the standard
curves were prepared as described in Material and Methods
Standard preparation section. The absorbance of each aliquot was
read against a blank of only guanidine hydrochloride 6M. Data
depicted correspond to one of the standard curves obtained.
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Figure 3 Aldol-proteins formation in the NADPH-dependent
microsomal peroxidation. The products of catalyzed microsomal
peroxidation increase the absorbance of the control sample at 266
nm by a factor of more than 14 (Bars #1 vs. #3). When sodium
bisulfite was added at the end of the incubation period of
peroxidation, the absorbance fell (Figure 3, #4), and reached values
close to its control. Even in the control case, a fall of the initial
amount could be observed with the addition of bisulfite (Bars #1 vs.
#2). Bisulfite interferes directly with carbonyl groups derived from
aldehydes in the aldolic condensation. * p < 0.01; **p < 0.0001
compared with all the other groups.
Table 1 Amount of the protein carbonyls and aldol-
proteins in serum samples
Control
group
n=2 1
Diabetic
Nephropathy
n=1 8
p
value
Carbonyl protein
(nmol/mg of protein)
1.17 ± 0.32 1.74 ± 0.54 0.004
Aldol-proteins
(μg/mg of protein)
106.75 ± 5.7 123.35 ± 14.9 0.0001
Carbonyl protein
after aldehyde
capture
(nmol/mg of protein)
1.09 ± 0.17 3.24 ± 0.55 0.002
GFR*
(ml/min/1.73 m
2)
90.9 ± 5.3 30.4 ± 14.3 0.00002
*Glomerular Filtration Rate
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In the present work we have described a procedure to
calculate the protein carbonyl content derived from unsa-
turated aldehydes, by the use of changes experimented by
the albumin molecule at alkaline pH. Formation of stable
adducts or aldol-proteins in serum samples constitute a
practical and novelty strategy to measure the carbonyl
stress derived from lipid peroxidation.
Lipid peroxidation is one of the principal outcomes of
carbonyl stress damage to biological components. The
most abundant products of lipid peroxidation are alde-
hydes such as acrolein, malondialdehyde (MDA), 4-
hydroxy-2-nonenal (HNE) and 4-hydroxy-2-hexenal
(HHE), and are frequently measured as indicators of
lipid peroxidation [26]. Conjugated diene measurement
is useful in studies of pure lipids and it measures an
early stage in the peroxidation process [27]. The mea-
surement of malondialdehyde (MDA) by the thiobarbi-
turic acid reactive substances assay (TBARS) is generally
not a good method when applied to biological samples,
although it has been widely utilized in the past [28].
These compounds and some others like isoprostanes are
all measurable in biological fluids but the analytical
methods used turned out to be complex and require
sample preparation involving extraction and purification
steps [29].
In the present work, we calculated the abundance of
alpha beta unsaturated aldehydes in the plasma of dia-
betic patients with and without renal damage. We used
a simple procedure to calculate the content of aldehydes
captured by serum proteins. First we used microsomal
membranes to demonstrate the aldehyde condensation-
dependent absorbance increase at 266 nm and the plau-
sible protein-dependent aldehyde capture. The aldehyde
incorporation to proteins appears as independent com-
ponent of carbonyl stress in serum of diabetic nephro-
p a t h yp a t i e n t s .T h ea l d e h y d ei n c o r p o r a t i o nw a s
abolished in the microsomal peroxidation NADPH-
dependent through the use of sodium bisulfite, an effi-
cient nuclephile agent that removes aldehyde groups by
attacking the carbon atom of the carbonyl group. Addi-
tionally, the intense aldehyde-capture derived from the
microsomal peroxidation helps us to find the source of
these particular aldehydes in the unsaturated fatty acids
derived from membrane phospholipids.
The oxidation of biomolecules such as carbohydrates
and lipids and/or the inadequate detoxification of carbo-
nyl compounds may contribute to the progression of
complications of end-stage renal disease [30]. A better
understanding of the nature of carbonyl stress in dia-
betic glomerular lesions would help in the search for
novel approaches to confront diabetic renal damage.
Additionally, if the generation of reactive carbonyl com-
pounds is not only secondary to oxidative stress but also
an active contributor to the renal disease pathogenesis,
as has been suggested [31,32], an inhibition of protein
carbonylation reaction might be relevant, and the
approaches to measuring the aldehydes abundance
might be very useful in the development of new treat-
ment strategies.
From the results obtained we can corroborate the
importance of unsaturated aldehydes in the uremic
plasma as an independent parameter of carbonyl stress.
In addition, we are in a position to propose an alterna-
tive explanation of why alkalinization of urine attenu-
ates rhabdomyolysis-induced renal dysfunction [33-35].
Although one acceptable explanation is that alkaliniza-
tion enhances the myoglobin (Mb) solubility [34] and
that lipid peroxidation reactions are accelerated at
acidic pH [35,36], a plausible alternative can be
deduced from data presented here, suggesting that
alpha-beta-unsaturated compounds condensation cata-
lyzed at alkaline pH could reduce renal dysfunctions
during rabdomyolisis. It is possible to suppose that
polymerization of reactive aldehydes represents a way
to block carbonyl groups in large amounts and pro-
mote carbonyl stress amelioration.
Materials and methods
Unless noted otherwise, biochemicals were obtained
from Sigma Chemical Co., St. Louis, MO; albumin from
bovine serum (BSA) (fraction V, lyophilized powder
9 8 % ) ;a l b u m i nf r o mh u m a ns e r u m( l y o p h i l i z e dp o w d e r
99%); 2, 4-dinitrophenylhydrazine (DNPH); ethylenedia-
minetetraacetic acid (EDTA); guanidine hydrochloride;
acrolein (2-propenal) 99%, sodium bisulfite (sodium
hydrogensulfite ≥ 99%) and sodium hydroxide (Sigma
Ultra 98%); nicotinamide; adenosine 5’- diphosphate
sodium salt (ADP), ferric Chloride (FeCl3) and b-Nicoti-
namide adenine dinucleotide phosphate reduced form
(b-NADPH).
Samples
Serum aliquots of diabetic patients of the Unit of
Nephrology at General Hospital # 80 of the Mexican
Institute of Social Security, Morelia, Michoacán, México
were collected from samples that were used in the peri-
odic clinical examinations. Control serum samples were
collected from individuals recruited for blood donations.
All patients received and gave both oral and written
informed consent for the use of the aliquot samples.
Blood samples were obtained in the morning after fast-
ing by venipuncture in tubes without anticoagulant.
Serum (21 controls and 18 diabetic with nephropathy)
was stored at -30°C and in all cases was used 3 days
after being collected. Animal samples. Hepatic tissue
from Sprague Dowley male rats weighing 200-250 g was
used. Animal procedures and management were made
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G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i m a l sa n d
approved by the Ethics Committee of the Mexican Insti-
tute of Social Security.
Acrolein capture by albumin and protein adducts (Aldol-
proteins) measurement
Standard preparation. An adduct acrolein-albumin stan-
dard curve was prepared as follows: 5 mg of human or
bovine serum albumin was dissolved completely in 5 ml
PBS and then incubated at room temperature with acro-
lein (10 μM final concentration), 100 μlo f0 . 0 1m M
EDTA and 100 μl of a 1% sodium hydroxide solution.
Aldolic condensates were formed this way in a time
dependent manner (Figure 1). The reaction mixture was
neutralized with HCL (2N) and dialyzed overnight
against PBS at 4°C. Aliquots containing increasing
amounts of protein were precipitated using 30% ZnSO4
and centrifuged 15 minutes at 5, 000 g; the pellets were
dissolved with 6M guanidine hydrochloride and incu-
bated at 37°C for 2 hours with occasional vortex mixing.
The absorbance of each aliquot was read with a spectro-
photometer at 266 nm (aldolic condensation) against a
blank of only guanidine hydrochloride 6M. The standard
curve performed represents the linear relationship
between the protein-acrolein adducts concentration or
aldol-protein abundance and the absorbance at 266 nm
(Figure 2, aldol-protein). Different alpha-beta unsatu-
rated incubated with albumin and aldehydes in protein-
free solutions present strong absorbance at 266 nm,
although acrolein showed the maximal efficiency in
adduct formation [27,28].
Parallel standard curves were made in the same condi-
tions with only albumin and albumin plus acrolein with-
out the addition of sodium hydroxide (Figure 2, albumin
and albumin plus acrolein). The standard curves per-
formed in this way correspond to the indirect absorbance
of albumin (and albumin plus acrolein) at 266 nm, as a
consequence of its intrinsic absorbance at 280 nm.
Sample procedure. Serum samples (15 μl) dissolved in
50 μlo fP B S ,2 5μlo f0 . 1m ME D T Aa n d5 0μlo f1 %
sodium hydroxide were incubated for 20 minutes at 37°
C. At the end of incubation, samples were precipitated
with 50 μlo fZ n S O 4 30%, dissolved with an additional
500 μl of PBS and centrifuged for 15 minutes at 5000 g.
Pellets were washed two more times with 0.5 ml of PBS
and finally dissolved with 6M guanidine hydrochloride
and incubated at 37°C for 2 hours with occasional vor-
tex mixing. The absorbances of the samples were read
with a spectrophotometer at 266 nm against a blank of
only guanidine hydrochloride 6M, as explained
previously.
Protein concentration was determined by the Bradford
reagent and then the concentration used of each sample
was adjusted with PBS. To the final concentration of
protein in guanidine, standard curves of Bradford proce-
dure were carried out substituting the vehicle by guani-
dine 2M and taking aliquot of 10 μlo fp r o t e i n
guanidine samples.
Using the absorbances of 266 nm and the slopes of
the standard curves described previously (Figure 2) the
Aldol-Protein concentration can be calculated as
follows:
Aldol-Protein = (Abs 266 nm - F) (N2), where F is the
calculated absorbance of albumin + acrolein mix (no
aldol) at 266 nm and N2 corresponds to the slope of
the aldol-protein adduct standard curve.
F = (Abs 266 nm) (N1) - (Abs 266 nm) (N2)/(N1),
where N1 and N2 are the slopes of the standard curves
of albumin + acrolein mix (no aldol) and aldol-protein
respectively (1851 and 411 for the standard curves pre-
sented in Figure 2)
Microsomal peroxidation catalyzed by NADPH
Microsomes. Hepatic tissue from Sprague Dowley rats
was homogenized in 25 M sucrose. The homogenate
was placed in a centrifuge tube and an equivalent
volume of 0.34 M sucrose was layered underneath. The
discontinuous gradient thus formed was centrifuged for
10 minutes at 700 × g, and before eliminating the crude
nuclei, the supernatant was centrifuged 10 minutes at
15, 000 × g. The precipitate (crude mitochondrial frac-
tion) was discarded and the supernatant centrifuged at
105, 000 × g for 60 minutes. The crude microsomal
fraction resultant was re-suspended in KCL 125 mM (1
ml of solution/g of liver used for the preparation) for a
concentration of 12.0 mg of microsomal protein/mL).
Microsomal Peroxidation. The induction of lipid per-
oxidation on microsomal membranes was carried out
with a controlled system described previously [37,38]
and with a reaction mix containing 20 mM nicotina-
mide, 2 mM ADP, 0.12 mM FeCl3,a n d0 . 4m M
NADPH in a 80 mM KCl solution. The control samples
without peroxidation were prepared as previously
described but without the addition of NADPH (Figure
3, MICROSOMES NO PEROXIDATION). In the
experimental procedure to inhibit lipid peroxidation by
blocking the carbonyl groups, sodium bisulfite (0.01
μM) was added to the reaction mix at the end of the
incubation time (1 h). The pH of the samples had been
previously neutralized.
Protein Carbonyl Measurement
Protein carbonyl determination was carried out in
accordance with previous reports [39]. Protein samples
containing 6 mg/ml of protein were re-suspended in 1
ml of 10 mM 2, 4-dinitrophenylhydrazine (DNPH) in 2
M HCl. The samples were incubated at laboratory
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ute intervals. The samples that had been previously pre-
cipitated with trichloroacetic acid (20%), centrifuged at
11, 000 × g for 10 minutes and re-suspended with a
pulse of sonication, were washed three times with 1 mL
of ethanol-ethyl acetate (1:1; v/v) to remove the residual
DNPH reagent. The final precipitates were dissolved in
6 N guanidine hydrochloride solution (1 mL). The pro-
tein carbonyl content was determined by measuring the
absorbance of the protein-2, 4 dinitrophenylhydrazone
derivatives at 375 nm, using a molar absorption coeffi-
cient of 22, 000 M
-1 cm
-1.
Statistical Analysis
Results were expressed as mean ± standard deviation
(SD). Groups were compared using one way ANOVA
test followed by Dunet’s test.
Additional material
Additional file 1: Aldehyde condensation from unsaturated fatty
acids and in absence of proteins. Unsaturated aldehydes from the free
fatty acid (FFA) lipid peroxidation can be condensed at alkaline pH and
produce a strong absorbance at 266 nm. Ferric ions (Fe) and glucose
(GLU) autoxidation catalyzed by traces of transition metals are the most
probable source of lipid peroxidation (references 23 and 24) and
aldehyde production in a time dependent slow rate (24 hours) reaction.
The maximal aldol-protein production was obtained with the additive
effect of GLU and ferric ions (FFAs + Glu + Fe
3+), but even with the use
of a nitrogen environment some amount of autoxidation of FFAs
generates unsaturated aldehydes and aldolic condensation such as can
be observed in the left short bar.
Additional file 2: Validated carbonyl proteins introduction to the
serum samples derived from aldehyde capture. The differences in
carbonyl content of the serum samples before and after aldehyde
capture treatment were corroborated. The results demonstrated the
incorporation of the carbonyl groups to the serum proteins and aldol-
protein formation from aldehyde capture (p = 0.002). Only the samples
of patients with diabetic nephropathy and higher level of aldol proteins
presented at the same time higher levels of protein carbonyls. Results
and samples correspond to the data presented in the text in Table 1.
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